Proov
Steven Sandquist began their career in 2020 when they took on the role of Business Development at Uwill. In the same year, they also became the Chief Operating Officer and minority owner of Mothership. In 2021, Sandquist became the Co-CEO of Business Development at InformedHC, Business Development Consultant at Sapphire RCMS, LLC, Chief Revenue Officer, Chief Operating Officer, and minor owner at Crosswalk Health. Currently, Sandquist is the Managing Director of Rocking Horse Accelerator, President of Gut Feel(sm), Business Development Consultant at Meomind, shareholder at Voyage RCM, and Business Development at Proov.
Steven Sandquist attended Western Illinois University from 1981 to 1985, where they earned a degree in Business, majoring in Marketing. Steven then attended Loyola University of Chicago - Graduate School of Business from 1985 to 1987, where they earned an M.B.A. in Personnel Management.
This person is not in any teams
This person is not in any offices
Proov
2 followers
Proov offers a suite of in vitro diagnostics to provide fertility insights throughout the entire menstrual cycle. When paired with the free Proov Insight app, Proov's easy, at-home pee tests provide a science-backed fertility coach right in your hand. First, a woman can measure all of the menstrual hormones daily with Proov tests, then snap a photo of each test within the Insight app. Then, a woman can follow the in-app prompts throughout her cycle to understand ovulation status, get daily insights and an Ovulation Insights score. Finally, the app generates a personalized action plan to maximize her wellness or develop a fertility strategy. Proov was founded by Amy Beckley, Ph.D, the "infertile scientist," after three years of infertility and seven miscarriages. Amy applied her own science expertise to uncover a luteal phase defect (a problem with ovulation quality). With help from her doctor and a simple supplement, Amy was able to get pregnant with her daughter. Proov is a venture capital backed company and the leader in understanding hormone health on the basis of tracking PdG, a metabolite of progesterone.